Health
FDA approves marketing of first AI-based device to assist clinicians during colon cancer screening – News-Medical.net
Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI) based on machine learning…
Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI) based on machine learning to assist clinicians in detecting lesions (such as polyps or suspected tumors) in the colon in real time during a colonoscopy.
Artificial intelligence has the potential to transform health care to better assist health care providers and improve patient care. When AI is combined with traditional screenings or surveillance methods, it…
-
General13 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
Noosa News15 hours agoSearch for man who ‘faked death’ slowed by unusual French law
-
Noosa News21 hours agoQueensland Rail retires iconic electric train fleet after more than four decades
-
Business18 hours ago2 ASX 200 large-cap shares that this fundie is cashing in after phenomenal growth